Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Marker Therapeutics (MRKR) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Marker Therapeutics (MRKR) over the last 6 years, with Q2 2025 value amounting to $117444.0.

  • Marker Therapeutics' Other Non Operating Income changed N/A to $117444.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $117444.0, marking a year-over-year change of. This contributed to the annual value of $31000.0 for FY2020, which is 7222.22% up from last year.
  • Per Marker Therapeutics' latest filing, its Other Non Operating Income stood at $117444.0 for Q2 2025.
  • In the past 5 years, Marker Therapeutics' Other Non Operating Income registered a high of $117444.0 during Q2 2025, and its lowest value of $117444.0 during Q2 2025.